14-Nov-2025 Two drugs that treat prostate cancer may also be effective against leukemia Penn State Peer-Reviewed Publication Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn State. AML, a cancer of blood and bone marrow, can affect people of all ages but is the most common type of leukemia in adults. Journal Blood Advances Funder American Institute for Cancer Research, NIH/National Institutes of Health, U.S. Department of Agriculture
14-Nov-2025 Researchers explore the brain’s ‘cleanup crew’ for non-opioid pain relief Texas A&M University Scientists in the laboratory of Shashank M. Dravid, PhD, in the Department of Psychiatry and Behavioral Sciences at the Texas A&M University Naresh K. Vashisht College of Medicine are working to understand the link between chronic pain and autophagy, the cell’s cleanup crew. Funder NIH/National Institutes of Health
14-Nov-2025 Wild birds are driving the current U.S. bird flu outbreak University of Pennsylvania Peer-Reviewed Publication Highly pathogenic avian influenza viruses—those responsible for bird flu outbreaks—continue to pose challenges for human and animal health. New research led by microbiologist Louise Moncla of the Unviersity of Pennsylvania tracked H5N1 viruses in North America to better understand the role wild birds play in the current bird flu outbreak. These findings could lead to a shift in risk management and outbreak control measures. Journal Nature Funder NIH/National Institutes of Health, Centers of Excellence for Influenza Research and Response (CEIRR)
14-Nov-2025 A new theory of molecular evolution University of Michigan Peer-Reviewed Publication A University of Michigan study proposes a new theory of molecular evolution. Journal Nature Ecology & Evolution Funder NIH/National Institutes of Health
13-Nov-2025 Biomedical Sciences researcher receives nearly $7 million in federal grants to fight STIs Georgia State University Grant and Award Announcement Cynthia Nau Cornelissen, a Distinguished University Professor and associate director of the Institute for Biomedical Sciences at Georgia State University, has received nearly $7 million in two, five-year federal grants to develop vaccines and therapeutics to combat sexually transmitted infections (STIs). Funder NIH/National Institute of Allergy and Infectious Diseases